z-logo
open-access-imgOpen Access
Longitudinal Intravital Imaging of Tumor-Infiltrating Lymphocyte Motility in Breast Cancer Models
Author(s) -
Inwon Park,
Sujung Hong,
Joon Seok,
Stephani Edwina Lucia,
Eunjoo Song,
Mingyo Kim,
Eunji Kong,
Hyun-Ji Seo,
Yoonha Hwang,
Soyeon Ahn,
Seonghye Kim,
DongHyun Jang,
Jae Hyuk Lee,
Su–Hyung Park,
Pilhan Kim,
You Hwan Jo
Publication year - 2021
Publication title -
journal of breast cancer/journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1
H-Index - 36
eISSN - 2092-9900
pISSN - 1738-6756
DOI - 10.4048/jbc.2021.24.e40
Subject(s) - motility , intravital microscopy , tumor infiltrating lymphocytes , medicine , breast cancer , tumor microenvironment , pathology , lymphocyte , cancer , cancer research , immunology , immunotherapy , biology , microcirculation , microbiology and biotechnology
Immunoreactive dynamics of tumor-infiltrating lymphocytes (TILs) within the tumor microenvironment in breast cancer are not well understood. This study aimed to investigate the spatiotemporal cellular dynamics of TILs in breast cancer models. Breast cancer cells were implanted into the dorsal skinfold chamber of BALB/c nude mice, and T lymphocytes were adoptively transferred. Longitudinal intravital imaging was performed, and the spatiotemporal dynamics of TILs were assessed. In the 4T1 model, TILs progressively exhibited increased motility, and their motility inside the tumor was significantly higher than that outside the tumor. In the MDA-MB-231 model, the motility of TILs progressively decreased after an initial increase. TIL motility in the MDA-MB-231 and MCF-7 models differed significantly, suggesting an association between programmed death-ligand 1 expression levels and TIL motility, which warrants further investigation. Furthermore, intravital imaging of TILs can be a useful method for addressing dynamic interactions between TILs and breast cancer cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here